Treatment patterns and outcomes in patients with breast cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy-induced/febrile neutropenia: Results from the MONITOR-GCSF study

被引：0

作者：

Aapro, M. ^{[1
]}

Krendyukov, A. ^{[2
]}

Krivtsova, N. ^{[2
]}

Gascon, P. ^{[3
]}

机构：

[1] Inst Multidisciplinaire Oncol, Clin Genolier, Genolier, Switzerland

[2] Hexal AG, Holzkirchen, Germany

[3] Hosp Clin Barcelona, Div Med Oncol, Dept Hematol Oncol, Barcelona, Spain

来源：

EUROPEAN JOURNAL OF CANCER | 2018年 / 92卷

关键词：

PEGFILGRASTIM; MULTICENTER; CYCLE;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

207 (PB-10

引用

页码：S53 / S53

页数：1

共 2 条

[1] Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer [J].

Holmes, FA ;

Jones, SE ;

O'Shaughnessy, J ;

Vukelja, S ;

George, T ;

Savin, M ;

Richards, D ;

Glaspy, J ;

Mesa, L ;

Cohen, G ;

Dhami, M ;

Budman, DR ;

Hackett, J ;

Brassard, M ;

Yang, BB ;

Liang, BC .

ANNALS OF ONCOLOGY, 2002, 13 (06) :903-909

[2] Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer [J].

Holmes, FA ;

O'Shaughnessy, JA ;

Vukelja, S ;

Jones, SE ;

Shogan, J ;

Savin, M ;

Glaspy, J ;

Moore, M ;

Meza, L ;

Wiznitzer, I ;

Neumann, TA ;

Hill, LR ;

Liang, BC .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :727-731

← 1 →